University of Louisville technology that may inhibit pathway for cancer gets commercial partner
from UofL News
A University of Louisville-born invention that may help treat cancer now has a commercial partner. Qualigen Therapeutics Inc., a California biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, has signed a license agreement for the technology and plans to fund continued development with UofL to ready it for market.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063